Oral Intake During Labor

April 22, 2020 updated by: Jeanette Anderson, David Grant U.S. Air Force Medical Center

Unrestricted Low Fat, Low Residue Oral Intake During Labor: A Randomized Controlled Study

A randomized clinical trial (RCT) to evaluate the impact of unrestricted low fat, low residue oral intake during labor on maternal and neonatal outcomes as well as maternal satisfaction.

Study Overview

Detailed Description

This study is a quantitative, randomized experimental design study to determine the impact of unrestricted low fat, low residue oral intake during labor on the indicated outcome variables and patient satisfaction. The comparison group will continue standard care of being allowed a clear liquid during active labor (≥6cm dilation), while the experimental group would be allowed to self-regulate oral intake with a low fat, low residue diet during active labor.

Study Type

Interventional

Enrollment (Actual)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Travis Air Force Base, California, United States, 94535
        • USAF David Grant Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Active Duty and Department of Defense (DoD) beneficiary Pregnant women 18 years of age and older
  • 37 weeks gestation or greater at time of admission
  • singleton fetus
  • cephalic presentation
  • who plan to labor/deliver at DGMC (military beneficiaries).

Exclusion Criteria:

  • Morbid/severe obesity (pre-pregnancy BMI ≥40 kg/m2
  • diabetes
  • hypertension (to include pre-eclampsia or eclampsia)
  • previous cesarean section
  • uncontrolled gastroesophageal reflux disease (GERD) (symptomatic with medication)
  • past history or current diagnosis of hyperemesis gravidarum
  • food allergies to any items contained in the gastric/soft bland diet
  • patients utilizing nitrous oxide for labor analgesia (should this treatment be available at DGMC)
  • Difficult airway as defined by the anesthesia staff.
  • Mallampati score 3 or 4
  • Thyroid mental distance less than 7 cm or 3 finger breaths
  • Mouth opening less than 3 finger breaths
  • Short thick neck, Micrognathia
  • Further indications as determined by the anesthesia provider doing the anesthesia preoperative assessment (pregnancy in and of itself will not be considered a disqualification due to airway changes during labor)" in order to define difficult airway per anesthesia.
  • Under age 18
  • Additional clinical risk factors as determined by the care provider

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Routine care during labor (authorized clear liquid diet).
Active Comparator: Experimental Group
Patients in the experimental group will have a gastric soft/bland diet available, which will include lean protein, fruits, vegetables, and low-fat dairy. This will be ordered in the electronic medical record (EMR) and is a standard "non-select meal," referred to as a gastric/soft bland diet that is not based on patient's preferred menu selections.
Patients in the experimental group will have a gastric soft/bland diet available.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nausea
Time Frame: active labor (6cm or greater dilation) through delivery of the infant
# episodes
active labor (6cm or greater dilation) through delivery of the infant
Vomiting
Time Frame: active labor (6cm or greater dilation) through delivery of the infant
# episodes
active labor (6cm or greater dilation) through delivery of the infant
Duration of labor
Time Frame: active labor (6cm or greater dilation) through delivery of the infant
#hours/minutes
active labor (6cm or greater dilation) through delivery of the infant
Mode of delivery
Time Frame: at birth
cesarean section, operative vaginal delivery, spontaneous vaginal delivery
at birth
Aspiration
Time Frame: active labor (6cm or greater dilation) through delivery of the infant
# episodes
active labor (6cm or greater dilation) through delivery of the infant
Newborn APGAR Score
Time Frame: 5 min of life
< 7
5 min of life
Maternal Satisfaction
Time Frame: active labor (6cm or greater dilation) through delivery of the infant
open ended survey question
active labor (6cm or greater dilation) through delivery of the infant

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeanette M Anderson, MSN, David Grant Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2017

Primary Completion (Actual)

January 11, 2020

Study Completion (Actual)

January 11, 2020

Study Registration Dates

First Submitted

September 6, 2017

First Submitted That Met QC Criteria

September 7, 2017

First Posted (Actual)

September 8, 2017

Study Record Updates

Last Update Posted (Actual)

April 24, 2020

Last Update Submitted That Met QC Criteria

April 22, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • FDG20170006H

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Satisfaction

Clinical Trials on gastric soft/bland diet

3
Subscribe